HEXIGONE INHIBITORS LIMITED Financials
- Company number
- 10226176CopyCopy
- Registered office
- Unit 11&12 Mardon Park Baglan Energy Park, Baglan, Port Talbot SA12 7AX
- Incorporated
- 10/06/2016
Company snapshot
- Status
- Active
- Employees
- 10 (2024)
- Latest financial data
- 2024
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2024.
Net Assets
196.96%vs 20232023: £147.08K
Total Assets
29.14%vs 20232023: £1.00M
Cash in Bank
160.00%vs 20232023: £142.97K
Total Liabilities
7.65%vs 20232023: £584.21K
Employees
-1vs 20232023: 11
In 2024, HEXIGONE INHIBITORS LIMITED reported net assets of £436.76K. The same filing shows total assets of £1.30M, cash in bank of £371.71K and total liabilities of £628.90K. Reported headcount was 10 in 2024. Total Assets rose from £1.00M in 2023 to £1.30M in 2024 (29.14%). Okredo holds filed figures for 2021–2024; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
196.96%from £147.08K in 2023Year-on-year change
Net Assets as filed for 2021–2024. Every figure in this chart is also in the financial history table.
3-year financial trend (2022–2024)
How the figures HEXIGONE INHIBITORS LIMITED filed moved across the three reported years 2022, 2023 and 2024 — measured end to end rather than year on year.
Net Assets
-9.5%vs 2022-4.9% a year compound (CAGR)
Cash in Bank
-21.9%vs 2022-11.6% a year compound (CAGR)
Total Assets
-2%vs 2022-1% a year compound (CAGR)
Total Liabilities
+8.8%vs 2022+4.3% a year compound (CAGR)
Employees
-16.7%vs 2022-2Biggest increase
Total Liabilities+8.8%
£578.25K in 2022 to £628.90K in 2024
Biggest decrease
Cash in Bank-21.9%
£475.87K in 2022 to £371.71K in 2024
HEXIGONE INHIBITORS LIMITED's filings pull in both directions between 2022 and 2024. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, set against a fall in cash in bank, pointing to a tighter cash position. See the full year-by-year figures.
Ratios from the filed figures
Calculated from HEXIGONE INHIBITORS LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 33.68%2024
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 48.50%2024
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 59.11%2024
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 28.67%2024
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for HEXIGONE INHIBITORS LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Net Assets£ | 124.28K | 482.51K | 147.08K | 436.76K |
| Total Assets£ | 1.02M | 1.32M | 1.00M | 1.30M |
| Cash in Bank£ | 803.94K | 475.87K | 142.97K | 371.71K |
| Total Liabilities£ | 892.00K | 578.25K | 584.21K | 628.90K |
| Employees | 11 | 12 | 11 | 10 |
HEXIGONE INHIBITORS LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for HEXIGONE INHIBITORS LIMITED covering 2021–2024, across 5 reported indicators. The most recent reported year is 2024.
HEXIGONE INHIBITORS LIMITED reported net assets of £436.76K for 2024. That compares with £147.08K in 2023, a change of 196.96%.
HEXIGONE INHIBITORS LIMITED reported total assets of £1.30M for 2024. That compares with £1.00M in 2023, a change of 29.14%.
HEXIGONE INHIBITORS LIMITED reported cash in bank of £371.71K for 2024. That compares with £142.97K in 2023, a change of 160.00%.
HEXIGONE INHIBITORS LIMITED reported 10 employees in 2024, compared with 11 in 2023.
Between 2022 and 2024, HEXIGONE INHIBITORS LIMITED's net assets fell by 9.5%, cash in bank fell by 21.9%, total assets fell by 2% and total liabilities rose by 8.8%. Net assets contracted at 4.9% a year across the two years to 2024, from £482.51K to £436.76K. Reported headcount went from 12 in 2022 to 10 in 2024 (-2).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.